Cannvas MedTech Inc. (CSE:MTEC) (Frankfurt:3CM) (OTCPK:CANVF) (“Cannvas” or the “Company”), a leading digital cannabis educator and data company, is pleased to announce it will have a substantial presence at the 2019 Cantech Investment Conference, taking place January 29-30 at the Metro Toronto Convention Centre in the heart of the city’s downtown core.

“We are thrilled to be exhibiting our Cannabis Data AI technology and being part of the Cannabis and Big Data Panel. We have a significant presence at this year’s Cantech Investment Conference, and with it the opportunity to signal to investors how our Cannabis Data AI is at the cusp of driving substantial growth in the industry as a major catalyst for licensed producers and dispensaries here in Canada” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc.

Cannvas MedTech will be at booth 622 at this year’s Cantech conference, with speaking engagements scheduled on each day of the conference. On Tuesday, January 29, CEO Shawn Moniz will participate in a discussion panel on the subject of Cannabis and Big Data, moderated by a member of Toronto law firm Fogler Rubinoff LLP. On Wednesday, January 30, Shawn will take to the Paradigm Stage for a featured speaking appearance expected to stress the importance of cannabis analytics in a nascent industry, positioning Cannvas as a leading source of comprehensive and unbiased information on the behaviours of active and potential cannabis consumers across Canada.

While at the conference, the senior management team at Cannvas expects to meet and connect with hundreds of leading Canadian technology companies, schedule private meetings with business leaders and influencers, and learn more about potential partnership opportunities with like-minded organizations.

The Cantech Investment Conference is put on by Cambridge House International, producing North America’s largest resource conferences and Canada’s largest technology investment conference. For 25 years, Cambridge House has produced flagship must-attend events and provided industries with platforms for networking, education and investment discovery. Cantech is a hallmark event attracting investors and media from across North America to meet with Canadian innovation entrepreneurs.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation.


BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event:

Keep reading... Show less

Positive distributor feedback and strong consumer interest accelerating launch with distributors

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that its wholly-owned subsidiary Naturo Group has successfully completed its initial shipment of TRACE plant-based products to one of Japan’s largest beverage distributors.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced an additional refreshment of its board of directors to further strengthen its leadership in the cannabis industry.

Keep reading... Show less